Cargando…

Tumor Suppression by PD-1/PD-L1 Interaction Blockage in Mice Model

BACKGROUND: Overexpression of programmed cell death ligand 1 (PD-L1) in tumor cells and subsequent interaction with the programmed cell death protein 1 (PD-1) in tumor-infiltrating T cells cause an immune evasion of the tumor from cytotoxic T-cells. Therefore, inhibiting such interaction by a recomb...

Descripción completa

Detalles Bibliográficos
Autores principales:	Salehi, Shima, Ghaderi, Hajarossadat, Habibi-Anbouhi, Mahdi, Shoari, Alireza, Hassanzadeh Eskafi, Ayda, Sabouri, Alireza, Hosseininejad-Chafi, Mohammad, Ashja Ardalan, Arghavan, Ramezani, Behzad, Kazemi-Lomedasht, Fatemeh, Behdani, Mahdi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Brieflands 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9990516/ https://www.ncbi.nlm.nih.gov/pubmed/36896323 http://dx.doi.org/10.5812/ijpr-132329

Ejemplares similares

Development of polyclonal heavy chain antibodies targeting programmed death ligand-1
por: Oghalaie, Akbar, et al.
Publicado: (2023)

Development of camelid monoclonal nanobody against SLC39A6 zinc transporter protein
por: Ghaderi, Hajarossadat, et al.
Publicado: (2021)

In vivo solid tumor targeting with recombinant VEGF-diphtheria immunotoxin
por: Hosseininejad-Chafi, Mohammad, et al.
Publicado: (2022)

Design of a humanized anti vascular endothelial growth factor nanobody and evaluation of its in vitro function
por: Kazemi-Lomedasht, Fatemeh, et al.
Publicado: (2018)

Developing and characterizing a single-domain antibody (nanobody) against human cytotoxic T-lymphocyte-associated protein 4 (hCTLA-4)
por: Sotoudeh, Nazli, et al.
Publicado: (2021)

Protective responses of an engineered PspA recombinant antigen against Streptococcus pneumoniae
por: Akbari, Elaheh, et al.
Publicado: (2019)

Cell-specific targeting by engineered M13 bacteriophage expressing VEGFR2 nanobody
por: Ranjibar, Farideh, et al.
Publicado: (2018)

In vivo immunotherapy of lung cancer using cross-species reactive vascular endothelial growth factor nanobodies
por: Kazemi-Lomedasht, Fatemeh, et al.
Publicado: (2017)

Development and characterization of single domain monoclonal antibody against programmed cell death ligand-1; as a cancer inhibitor candidate
por: Oghalaie, Akbar, et al.
Publicado: (2022)

Expressing of Recombinant VEGFR2-specific Nanobody in Baculovirus Expression System
por: Shokrollahi, Narjes, et al.
Publicado: (2021)

In vitro combination therapy of pathologic angiogenesis using anti-vascular endothelial growth factor and anti-neuropilin-1 nanobodies
por: Mohseni, Nastaran, et al.
Publicado: (2020)

A Model to Study the Phenotypic Changes of Insect Cell Transfection by Copepod Super Green Fluorescent Protein (cop-GFP) in Baculovirus Expression System
por: Shokrollahi, Narjes, et al.
Publicado: (2016)

A nanobody-derived mimotope against VEGF inhibits cancer angiogenesis
por: Karami, Elmira, et al.
Publicado: (2020)

The biomarkers of hyperprogressive disease in PD-1/PD-L1 blockage therapy
por: Wang, Xueping, et al.
Publicado: (2020)

Characteristics and Lethality of a Novel Recombinant Dermonecrotic Venom Phospholipase D from Hemiscorpius lepturus
por: Torabi, Elham, et al.
Publicado: (2017)

Preparation and characterization of a novel nanobody against T-cell immunoglobulin and mucin-3 (TIM-3)
por: Homayouni, Vida, et al.
Publicado: (2016)

Designing and Development of a Tandem Bivalent Nanobody against VEGF(165)
por: Khodabakhsh, Farnaz, et al.
Publicado: (2021)

Datasets of a novel bivalent single chain antibody constructed by overlapping oligonucleotide annealing method targeting human CD123
por: Moradi-Kalbolandi, Shima, et al.
Publicado: (2016)

Expression, purification, and characterization of a diabody against the most important angiogenesis cell receptor: Vascular endothelial growth factor receptor 2
por: Behdani, Mahdi, et al.
Publicado: (2012)

Tislelizumab uniquely binds to the CC′ loop of PD‐1 with slow‐dissociated rate and complete PD‐L1 blockage
por: Hong, Yuan, et al.
Publicado: (2021)

Peptide-directed Pd-decorated Au and PdAu nanocatalysts for degradation of nitrite in water
por: Mosleh, Imann, et al.
Publicado: (2021)

Supramolecular Photothermal Nanomedicine Mediated Distant Tumor Inhibition via PD-1 and TIM-3 Blockage
por: Huang, Tong-Yi, et al.
Publicado: (2020)

Blockage of CacyBP inhibits macrophage recruitment and improves anti-PD-1 therapy in hepatocellular carcinoma
por: Wang, Jialiang, et al.
Publicado: (2023)

Immunity-Related Gene Signature Identifies Subtypes Benefitting From Adjuvant Chemotherapy or Potentially Responding to PD1/PD-L1 Blockage in Pancreatic Cancer
por: Qian, Hao, et al.
Publicado: (2021)

PD-L1/PD-1 blockage enhanced the cytotoxicity of natural killer cell on the non-small cell lung cancer (NSCLC) by granzyme B secretion
por: Qiao, Duan-Rui, et al.
Publicado: (2023)

A Systematic Review on PD-1 Blockade and PD-1 Gene-Editing of CAR-T Cells for Glioma Therapy: From Deciphering to Personalized Medicine
por: Abdoli Shadbad, Mahdi, et al.
Publicado: (2022)

PD-1 Blockage Reverses Immune Dysfunction and Hepatitis B Viral Persistence in a Mouse Animal Model
por: Tzeng, Horng-Tay, et al.
Publicado: (2012)

Dual blockage of both PD-L1 and CD47 enhances immunotherapy against circulating tumor cells
por: Lian, Shu, et al.
Publicado: (2019)

Targeting GPC3(high) cancer-associated fibroblasts sensitizing the PD-1 blockage therapy in gastric cancer
por: Li, Dinuo, et al.
Publicado: (2023)

Infectious and coronary artery disease
por: Rezaee-Zavareh, Mohammad Saeid, et al.
Publicado: (2016)

Triggering of lymphocytes by CD28, 4-1BB, and PD-1 checkpoints to enhance the immune response capacities
por: Kaviani, Elina, et al.
Publicado: (2022)

PD-1 blockage combined with vaccine therapy can facilitate immune infiltration in tumor microenvironment of Lynch syndrome colon cancer
por: Ye, Kai, et al.
Publicado: (2022)

Prioritizing the factors affecting adoption of e-commerce using multi-criteria decision making techniques in Tehran hospitals in 2021
por: Ardalan, Shahrzad Ashja, et al.
Publicado: (2022)

Generation of Human Micro-Doppler Signature Based on Layer-Reduced Deep Convolutional Generative Adversarial Network
por: Ostovan, Mahdi, et al.
Publicado: (2022)

The Tumor Microenvironment: A Milieu Hindering and Obstructing Antitumor Immune Responses
por: Labani-Motlagh, Alireza, et al.
Publicado: (2020)

Elimination Phase of Measles: an Epidemiological Survey in Gonabad (Iran) during 2006-2010
por: Hamed, Ramezani A., et al.
Publicado: (2012)

Dual blockage of both PD-L1 and CD47 enhances the therapeutic effect of oxaliplatin and FOLFOX in CT-26 mice tumor model
por: Alimohammadi, Reza, et al.
Publicado: (2023)

Effectiveness of Plasmocure™ in Elimination of Mycoplasma Species from Contaminated Cell Cultures: A Comparative Study versus Other Antibiotics
por: Molla Kazemiha, Vahid, et al.
Publicado: (2019)

The Latest Findings of PD-1/PD-L1 Inhibitor Application in Gynecologic Cancers
por: Kooshkaki, Omid, et al.
Publicado: (2020)

Application of a Synthetic Polymer Nanocomposite Latex in a Wellbore Cement Slurry for Gas Blockage Functions
por: Bazrkar, Hamid, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_um2d31hq8vr4ac5r8mbp4udqts